Towards a systems approach for chronic diseases, based on health state modeling

F1000Research
Michael Rebhan

Abstract

Rising pressure from chronic diseases means that we need to learn how to deal with challenges at a different level, including the use of systems approaches that better connect across fragments, such as disciplines, stakeholders, institutions, and technologies. By learning from progress in leading areas of health innovation (including oncology and AIDS), as well as complementary indications (Alzheimer's disease), I try to extract the most enabling innovation paradigms, and discuss their extension to additional areas of application within a systems approach. To facilitate such work, a Precision, P4 or Systems Medicine platform is proposed, which is centered on the representation of health states that enable the definition of time in the vision to provide the right intervention for the right patient at the right time and dose. Modeling of such health states should allow iterative optimization, as longitudinal human data accumulate. This platform is designed to facilitate the discovery of links between opportunities related to a) the modernization of diagnosis, including the increased use of omics profiling, b) patient-centric approaches enabled by technology convergence, including digital health and connected devices, c) increasin...Continue Reading

References

Apr 15, 1993·Annals of Internal Medicine·G H GuyattD L Patrick
Feb 28, 2002·Journal of the American Academy of Dermatology·David J MargolisMona Baumgarten
May 5, 2004·The Journal of Cell Biology·Kendall Powell
Dec 16, 2004·Environmental Health Perspectives·Angela Spivey
Sep 19, 2006·Nature Reviews. Microbiology·Thomas Lengauer, Tobias Sing
Dec 16, 2006·BMJ : British Medical Journal·Nick Black
Mar 22, 2008·Journal of Zhejiang University. Science. B·Xiao-e YangZhen-li He
Jun 13, 2008·Nature·Declan Butler
Jun 27, 2008·Annals of the New York Academy of Sciences·Rachel Nugent
Sep 3, 2008·Alimentary Pharmacology & Therapeutics·C D ZoisE V Tsianos
Dec 25, 2008·Journal of Lipid Research·Robert W MahleyYadong Huang
Apr 22, 2010·Clinical Pharmacology and Therapeutics·B Munos
Sep 18, 2010·Journal of the American Podiatric Medical Association·Vickie R DriverGary Gibbons
Jan 14, 2011·Plastic and Reconstructive Surgery·Nathan A HuntLawrence A Lavery
Jan 14, 2011·Nature·George Poste
Mar 3, 2011·JAMA : the Journal of the American Medical Association·Simon C Mathews, Peter J Pronovost
Jul 13, 2011·Genome Medicine·Jean BousquetCharles Auffray
Oct 1, 2011·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·G M PesM Maioli
Oct 13, 2011·Neurorehabilitation and Neural Repair·Bruce H Dobkin, Andrew Dorsch
May 3, 2012·Clinical Pharmacology and Therapeutics·R B Altman
Aug 17, 2012·Journal of Biomedical Optics·Susanne Lange-AsschenfeldtBernhard Lange-Asschenfeldt
Dec 21, 2012·Pharmacogenomics·Christof KoelschPeter Keeling
May 15, 2013·Journal of Leukocyte Biology·Margaret K Callahan, Jedd D Wolchok
Jun 8, 2013·Dermatologic Therapy·Nanjin J ParkVickie R Driver
Sep 27, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Leah C BurnsGilbert L'italien
Dec 12, 2013·Journal of Primary Care & Community Health·Monica A Fisher, Zhen-Qiang Ma
Jan 15, 2014·Bioinformatics·Simon JuppAndrew M Jenkinson
Feb 26, 2014·Nature Reviews. Immunology·Antonella PellicoroJonathan A Fallowfield
Mar 19, 2014·The Journal of Endocrinology·Ling HeFredric E Wondisford
May 23, 2014·Drug Discovery Today. Technologies·Thomas LengauerRolf Kaiser
Jan 1, 2013·Personalized Medicine·Mauricio FloresLeroy Hood
Jan 22, 2015·Social Science & Medicine·Eric D Carter
Aug 14, 2015·Science Translational Medicine·Sam HawgoodKeith R Yamamoto
Aug 19, 2015·Brain : a Journal of Neurology·Heiko Braak, Kelly Del Tredici
Nov 27, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Françoise Van Bambeke, Paul M Tulkens
Mar 11, 2016·Nature Biotechnology·Joseph C KvedarDaphne Zohar
Mar 16, 2016·Scientific Data·Mark D WilkinsonBarend Mons
Mar 27, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Colin Green, Shenqiu Zhang
May 24, 2016·International Journal of Molecular Sciences·Luis Calzadilla Bertot, Leon Anton Adams
Jun 14, 2016·IEEE Transactions on Bio-medical Engineering·Dagmar Waltemath, Olaf Wolkenhauer
Jun 22, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Magali HaasUNKNOWN Brain Health Modeling Initiative (BHMI)

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
biopsy
amputations
confocal microscopy

Software Mentioned

Aetionomy
ICHOM

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Alcohol Research & Health : the Journal of the National Institute on Alcohol Abuse and Alcoholism
Hans Peter Fischer
Drug Target Review
Ilyas Singeç, Anton Simeonov
© 2022 Meta ULC. All rights reserved